| Hans-Günter Meyer-Thompson | International
EMCDDA. New developments in national drug strategies in Europe
EMCDDA. New developments in national drug strategies in Europe
Summary
This paper gives an overview of some recent developments in the tools most commonly used to manage national drug policies: strategies, coordination mechanisms and evaluations. It is based on an analysis of reports on national drug policies compiled by the EMCDDA’s Reitox focal points in the EMCDDA reporting countries (28 EU Member States, plus Turkey and Norway), consultation with experts and scientific literature. (EMCDDA, Lissabon, November 2017)